Procuring digital preservation CAN be quick and painless with our new dynamic...
Introduction to Pain pathology
1. Pain pathways and Pharmacotherapy
of pain management
Dr. S. Parasuraman,
Faculty of Pharmacy,
AIMST University.
Course: PHARMACOTHERAPEUTICS II
2. Pain pathways
• Pain has a biologically important protective function.
• Manifestations of pain related to tissue injury including
hyperalgesia, an exaggerated response to a noxious
stimulus, and allodynia, the perception of pain from
normally innocuous stimuli.
• Hyperalgesia and allodynia are the result of changes in
either the peripheral or central nervous systems and
causes peripheral or central sensitization, respectively.
3. Pain pathways
• The ascending pathways that mediate pain consist of
three different tracts:
– Neospinothalamic tract
– Paleospinothalamic tract
– Archispinothalamic tract
9. Sources of PainPain
Somatic Pain
Cutaneous, Superficial
or Peripheral Pain
Deep pain
Visceral Pain
Thalamic Pain
Psychosomatic Pain
Referred Pain
Phantom (illusory)
Pain
Reaction to Somatic
Pain
• Startle response
• Autonomic response
• Behavioral response
10. Sources of Pain
• Visceral Pain: In the
visceral organs,
nociceptors respond
to mechanical
stimulation such as
pressure, tissue
damage, and
chemical stimulation.
11. Sources of Pain
• Thalamic Pain: It also called as Dejerive-Roussy
syndrome. Stroke or occlusion in the
thalamogeniculate artery, which supplies the
lateroposterior half of the thalamus, can result in a
thalamic lesion, which is often accompanied by
neurologic conditions several months after the initial
event.
• Neuropathic Pain: It is a sharp, shooting and
devastating pain.
• Psychosomatic Pain: Psychic reaction to pain includes
all the well-known responses to pain such as anguish,
anxiety, crying, depression, nausea and excess
muscular excitability through the body.
12. Sources of Pain
• Referred Pain: is a painful sensation at a site other
than the injured one. The pain is not localized to the
site of its cause (visceral organ) but instead is localized
to a distant site.
13. Sources of Pain
• Phantom (illusory) Pain: It is the experience of pain
without any signals from nociceptors.
14. Pathological classification of pain
• Nociceptive: represents the normal response to
noxious injury of tissues.
• Neuropathic: Pain initiated or caused by a primary
lesion in the somatosensory nervous system.
• Inflammatory: Activation and sensitization of the
nociceptive pain pathway by a variety of mediators
released at a site of tissue inflammation.
15. Time course: Pain duration
• Acute pain (less than 3 to 6 months duration): Pain
arises from activation of nociceptors for a limited time
and is not associated with significant tissue damage
(e.g., a pin prick).
• Chronic pain (more than 3-6 months): It is prolonged
pain lasting for months or longer that arises from
tissue injury, inflammation, nerve damage, tumor
growth, lesion or occlusion of blood vessels.
• Fibromyalgia: It is characterized by widespread chronic
pain throughout the body, including fatigue, anxiety
and depression.
16. Overview of inflammatory processes
• Inflammation begins when a stimulus, such as infection,
physical stress, or chemical stress, produces cellular
damage.
17. Overview of inflammatory processes
• The more important inflammatory mediators are the
eicosanoids, biological oxidants, cytokines, adhesion
factors, and digestive enzymes (proteases, hyaluronidase,
collagenase, and elastase).
• EICOSANOIDS: The pathway initiated by cyclooxygenase
(COX) produces prostaglandins; the lipoxygenase pathway
generates leukotrienes.
19. Overview of inflammatory processes
• Biological Oxidants: The biologically derived oxidants are
potent bacterial killers but are also a major contributing
factor in tissue injury that results from the inflammatory
response. These oxidants include the superoxide anion
(∙O2-), hydrogen peroxide (H2O2), nitric oxide (∙NO),
peroxynitrite (∙OONO∙), hypochlorous acid (HOCl),
peroxidase-generated oxidants of undefined character,
probably the hydroxyl radical (∙OH), and possibly singlet
oxygen (1O2).
• Cytokines: Tumor necrosis factor-α (TNF- α) and
interleukin 1(IL-1) are produced primarily by cells of
the monocyte–macrophage lineage.
20. Pharmacotherapy of acute pain
• SORT (The Strength-of-Recommendation Taxonomy):
key recommendations for practice
Read more:
Blondell RD, Azadfard M,
Wisniewski AM.
Pharmacologic therapy for
acute pain. Am Fam
Physician. 2013;87:766-72.
21. Pharmacotherapy of chronic pain
• Treatment algorithm for pharmacotherapy of chronic
non-cancer pain
Read more:
Lynch ME, Watson CP. The
pharmacotherapy of chronic
pain: a review. Pain Res Manag.
2006 ;11(1):11-38.